Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region

Journal of Clinical Investigation

Volumn 99, Issue 6, 1997, Pages 1361-1366

  Suzuki, Koji ^a   Kuriyama, Masaru ^b   Saito, Tetsuo ^a   Ichinose, Akitada ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

5' allele; atherosclerosis; cerebral infarction; gene regulation; myocardial infarction

Indexed keywords

APOLIPOPROTEIN A; BETA GALACTOSIDASE; CHLORAMPHENICOL ACETYLTRANSFERASE; LIPOPROTEIN A;

ARTICLE; BLOOD SAMPLING; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0030944935     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119295     Document Type: Article

References (40)

1. Berg, K. 1963. A new serum type system in man - the Lp(a) system. Acta Pathol. Microbiol. Scand. 59:369-382.
2. Utermann, G. 1989. The mysteries of lipoprotein(a). Science (Wash.DC). 246:904-910.
3. Scanu, A.M., and G.M. Fless. 1990. Lipoprotein(a): heterogeneity and biological relevance. J. Clin. Invest. 85:1709-1715.
4. Miles, L.A., and E.F Plow. 1990. An interloper into the fibrinolytic system? Thromb. Haemost. 63:331-335.
5. McLean, J.W., J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (Lond.). 330:132-137.
6. Harpel, P.C., B.R. Gordon, and T.S. Parker. 1989. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. USA. 86:3847-3851.
7. Loscalzo, J., M. Weinfeld, G.M. Fless, and A.M. Scanu. 1990. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis. 10:240-245.
8. Rouy, D., M.L. Koschinsky, V. Fleury, J. Chapman, and E. Angles-Cano. 1992. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry. 31:6333-6339.
9. Edelberg, J.M., M. Gonzalez-Gronow, and S.V. Pizzo. 1989. Lipoprotein(a) inhibits streptokinase-mediated activation of human plasminogen. Biochemistry. 28:2370-2374.
10. Rhoads, G.G., G. Dahlen, K. Berg, N.E. Morton, and A.L. Dannenberg. 1986. Lp(a) lipoprotein as a risk factor for myocardial infarction. Am. J. Med. Assoc. 256:2540-2544.
11. Murai, A., T. Miyahara, N. Fujimoto, M. Matsuda, and M. Kameyama. 1986. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 59:199-204.
12. Boerwinkle, E., H.J. Menzel, H.G. Kraft, and G. Utermann. 1989. Contribution of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) elycoprotein phenotypes to normal lipid variation. Hum. Genet. 82:73-78.
13. Boerwinkle, E., C.C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H.H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90:52-60.
14. Gavish, D., N. Azrolan, and J.L. Breslow. 1989. Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J. Clin. Invest. 84:2021-2027.
15. Lackner, C., E. Boerwinkle, C.C. Leffert, T. Rahmig, and H.H. Hobbs. 1991. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87:2153-2161.
16. Kraft, H.G., S. Kochl, H.J. Menzel, C. Sandholzer, and G. Utermann. 1992. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum. Genet. 90:220-230.
17. Perombelon, Y.F., A.K. Soutar, and B.L. Knight. 1994. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J. Clin. Invest. 93:1481-1492.
18. Krempeler, F., G.M. Kostner, K. Bolzano, and F. Sandhofer. 1980. Turnover of lipoprotein(a) in man. J. Clin. Invest. 65:1483-1490.
19. Rader, D.J., W. Cain, L.A. Zech, D. Usher, and H.B. Brewer. 1993. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J. Clin. Invest. 91:443-447.
20. Rader, D.J., W. Cain, K. Ikewaki, G. Tally, L.A. Zech, D. Usher, and H.B. Brewer. 1994. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to difference in Lp(a) catabolism but to differences in production rate. J. Clin. Invest. 93:2758-2763.
21. Azrolan, N., D. Gavish, and J.L. Breslow. 1991. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J. Biol. Chem. 266:13866-13872.
22. Ichinose, A. 1995. Characterization of the apolipoprotein(a) gene. Biochem. Biophys. Res. Commun. 209:365-371.
23. Ichinose, A., and M. Kuriyama 1995. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein(a). Biochem. Biophys. Res. Commun. 209:372-378.
24. Wade, D.P., G.E. Lindahl, and R.M. Lawn. 1994. Apolipoprotein gene transcription is regulated by liver-enriched trans-acting factor Hepatocyte Nuclear Factor 1α. J. Biol. Chem. 269:19757-19765.
25. Gaw, A., E. Boerwinkle, J.C. Cohen, and H.H. Hobbs. 1994. Comparative analysis of the apo(a) gene, glycoprotein, and plasma concentration of Lp(a) in three ethnic groups. J. Clin. Invest. 93:2526-2534.
26. Wade, D.P., J.G. Clarke, G.E. Lindahl, A.C. Liu, B.R. Zysow, K. Meer. K. Schwartz, and R.M. Lawn. 1993. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc. Natl. Acad. Sci. USA. 90:1369-1373.
27. Ichinose, A. 1992. Multiple members of plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry. 31:3113-3118.
28. Saiki, R.K., D.H. Gelfand, S.J. Stoffel, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Wash. DC). 239:487-491.
29. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-termination inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467.
30. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Plainview, NY.
31. Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
32. Hall, C.V., P.E. Jacob, G.M. Ringold, and F. Lee. 1983. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2:101-109.
33. Zysow, B.R., G.F. Lindahl, D.P. Wade, B.L. Knight, and R.M. Lawn. 1995. C/T polymorphism in the 5′-untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler. Arterioscler. Thromb. Vasc. Biol. 15:58-64.
34. Mooser, V., F.P. Mancini, S. Bopp, A. Petho-Schramm, R. Guerra, E. Boerwinkle, H.-J. Muller, and H.H. Hobbs. 1995. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum. Mol. Genet. 4:173-181.
35. Mizokami, A., and C. Chang. 1994. Induction of transcription by the 5′-untranslated region of human androgen receptor mRNA. J. Biol. Chem. 269: 25655-25659.
36. Genest, J., Jr., J.L. Jenner, J.R. McNamara, J.M. Ordovas, S.R. Silberman, P.W. Wilson, and E.J. Schaefer. 1991. Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. Am. J. Cardiol. 67:1039-1045.
37. Cooke, T., R. Sheahan, D. Foley, M. Reilly, G. D'Arcy, W. Jauch, M. Gibney, G. Gearty, P. Crean, and M. Walsh. 1994. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 89:1593-1598.
38. Parlavecchia, M., A. Pancaldi, R. Taramelli, P. Valsania, L. Galli, G. Pozza, S. Chierchia, and G. Ruotolo. 1994. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age. Am. J. Cardiol. 74:346-351.
39. Maeda, S., A. Abe, M. Seishima, K. Makino, A. Noma, and M. Kawade. 1989. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 78:145-150.
40. Henriksson, P., B. Angelin, and L. Berglund. 1992. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J. Clin. Invest. 89:1166-1171.